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NASAL SEPTUM CHONDROMA: A CASE REPORT
Chen-Yu Chien, Chih-Feng Tai, Kuen-Yao Ho, Ka-Wo Lee, Wen-Rei Kuo,
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Kaohsiung, Taiwan.
Chondromas of the nasal septum are rare. Since its first literary description in 1842, only about 140 cases
have been reported. We present the case of a 38-year-old female who reported intermittent nasal bleeding
and nasal obstruction for 3 months. A reddish mass arising from the nasal septum was found by endoscope.
The tumor was removed under endoscopic guidance and histopathologic examination revealed chondroma
composed of well-differentiated chondrocytes. No recurrence was noticed after 6 months of follow-up.
Despite their rarity, chondromas should be taken into consideration in the differential diagnosis of nasal
tumors, especially those arising from the nasal septum.
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Cartilaginous tumors commonly occur in the long bones,
pelvis, sternum, ribs and scapula. Only 10% of cases occur
in the head and neck region and those are most commonly
observed in the larynx and in the ethmoidosphenoidal
region [1,2]. A nasal chondroma is a benign tumor and
exceptionally rare in the nasal septum. Since its first
description by Morgan in 1842, only about 140 cases have
been recorded [2,3].
CASE PRESENTATION
A 38-year-old pregnant female who had suffered from
intermittent left nasal bleeding for 3 months visited our
clinic. She also complained of headaches, progressive left
nasal obstruction, postnasal drip, and sneezing. She had
no rhinorrhea, nasal pain, history of trauma, ophthalmic
symptoms, or facial deformity. Local findings and nasal
endoscope examination revealed a well-defined, smooth,
firm reddish mass arising from the left side of the nasal
septum (Figure 1). It had no contact with the sinus or tur-
binate. No cervical lymphadenopathy was present. Wide
excision of the mass with a Diomed laser (Diomed Inc,
Andover, MA, USA) was performed under local anesthesia
with the guidance of an endoscope on October 3, 2003. We
left a safe margin of 10 mm around the attached base. The
perichondrium was also removed, but the cartilage was
preserved since no bone or cartilage destruction was noted.
The tumor measured 1.0 × 0.8 × 0.5 cm. Nasal obstruction
and bleeding improved after surgery and the patient fully
Figure 1. A well-defined, reddish mass with congested vessels on the over-
lying mucosa on the left side of the nasal septum (arrow). S = nasal septum.
Nasal septum chondroma
143Kaohsiung J Med Sci March 2005 • Vol 21 • No 3
recovered. No sign of recurrence was noted after 6 months
of follow-up.
The result of the histologic study was compatible with
chondroma composed of well-differentiated chondrocytes,
without increased cellularity or nuclear atypia (Figure 2).
DISCUSSION
Although cartilaginous tumors of the head and neck are
rare, when they do occur, they are malignant twice as
frequently as they are benign [4,5]. Nasal chondromas are
more common among younger patients [3,6]. The peak age
of patients with cartilaginous tumors of the head and neck
is between 20 and 30 years, although cases have been ob-
served in patients up to and over the age of 60 [1,3]. There
is no connection to gender [3,4].
The symptoms of cartilage tumors of the nasal cavity
and its surroundings depend on the site, size, and rate of
growth of the tumor. Nasal chondromas are characterized
by slow growth, with the symptoms of nasal obstruction
and epistaxis [1,3]. Pain does not appear to be a prominent
symptom. Pressure effects and deformities may occur.
Interference with the orbital contents may cause proptosis,
epiphora, diplopia, and even blindness. Patients in whom
the maxilla is involved may complain of toothaches and ill-
fitting dentures.
As cartilaginous tumors of the head and neck region are
very large at the time of presentation, certainty as to their
exact site of origin and extent is difficult [1,6]. The sites of
predilection in the head and neck region include the ethmoid
sinus (50%), maxilla (18%), nasal septum (17%), hard palate
and nasopharynx (including the sphenoid and eustachian
tube) (6% each), and alar cartilage (3%) [3].
The most convincing theory of origin is that of carti-
laginous cell rests. Chondromas may arise from the em-
bryonal cartilage cell rests which may escape resorption
during enchondro-ossification [1,3,7].
The impact of pregnancy on the enlargement of
chondroma has been reported with regard to intracranial
tumors, including the skull base chondroma [8]. Nasal
septum chondroma presenting in pregnancy has not been
previously reported. The mechanism may be due to the
physiologic changes during pregnancy. The engorgement
of blood vessels may cause tumor expansion. Alternative-
ly, changes in hormonal levels, including those of estrogen
and progesterone, may influence tumor development.
Plain X-ray slides and computer tomographs help in
assessing the extent of the tumor. In general, nasal
chondromas are not radio-opaque [3]. Chondromas are
usually well circumscribed and appear fairly homogeneous
on a computed tomography scan [4].
Biopsy is the only certain means of diagnosis [3]. Some
chondrosarcomas are extremely well-differentiated and the
pathologist might have difficulty in separating these ma-
lignant lesions from benign ones, especially in the biopsy
material [1,5,7,9]. Twenty percent of head and neck chon-
drosarcomas may initially be misdiagnosed as benign
[4]. Multiple site biopsies are important in the assessment
of cartilaginous tumors, since areas diagnostic of chondro-
sarcoma may only be noted focally [5,7,9].
Although chondromas are regarded as benign, they
differ from other benign tumors in that they are locally in-
vasive and tend to recur after removal. They also have a
tendency toward sarcomatous change [1,3,6]. Neverthe-
less, in cartilaginous tumors of the nasal passages, as else-
where in the skeleton, less than 5% of tumors presenting
as clinically and histologically benign eventually be-
come malignant [10].
Wide surgical excision is the accepted treatment for
cartilaginous tumors in this region [3,7]. In general, carti-
laginous tumors are radioresistant. Radiotherapy is of lit-
tle value and chemotherapy is generally ineffective [3,5]. Ra-
diotherapy will be used usually when the patient’s disease
is beyond surgical cure [3]. As chondromas have a tendency
toward sarcomatous change, long-term follow-up is strong-
ly advised [2,3,9,10]. Although both benign and malignant
forms spread locally, metastasis is rare and occurs late with
Figure 2. Pathology reveals chondrocyte with normal cellularity. The
tumor is composed of vacuolated cytoplasm and prominent vesicular
nuclei. Mitotic figures are scarce. Mature chondrocytes have small,
single nuclei within lacunae without atypia. (Hematoxylin & eosin;
original magnification × 100.)
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chondrosarcoma, most commonly affecting the lungs [1].
Death from the tumor results from intracranial spread or
pulmonary complications [3]. The prognosis is good and
recurrence is uncommon with appropriate treatment.
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